RESÚMENES NOVIEMBRE 2004

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Requiere estar conectado a internet. Haga un click en la información del journal)

 

Hippocampal Volume and Depression: A Meta-Analysis of MRI Studies

Poul Videbech, and Barbara Ravnkilde

Am J Psychiatry 161:1957-1966, November 2004

Research Design Features and Patient Characteristics Associated With the Outcome of Antidepressant Clinical Trials

Arif Khan, Russell L. Kolts, Michael E. Thase, K. Ranga Rama Krishnan, and Walter Brown

Am J Psychiatry 161:2045-2049, November 2004

Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled Trial

Steven P. Roose, Harold A. Sackeim, K. Ranga Rama Krishnan, Bruce G. Pollock, George Alexopoulos, Helen Lavretsky, Ira R. Katz, and Heikki Hakkarainen, Old-Old Depression Study Group

Am J Psychiatry 161:2050-2059, November 2004

Comparison of Two-Phase Treatment With Imipramine or Fluvoxamine, Both Followed by Lithium Addition, in Inpatients With Major Depressive Disorder

Tom K. Birkenhäger, Walter W. van den Broek, Paul G. Mulder, Jan A. Bruijn, and Peter Moleman

Am J Psychiatry 161:2060-2065, November 2004

ß-Arrestin-1 Levels: Reduced in Leukocytes of Patients With Depression and Elevated by Antidepressants in Rat Brain

Sofia Avissar, Angela Matuzany-Ruban, Keren Tzukert, and Gabriel Schreiber

Am J Psychiatry 161:2066-2072, November 2004

Clinical Outcome of ECT in Patients With Major Depression and Comorbid Borderline Personality Disorder

Ulrike Feske, Benoit H. Mulsant, Paul A. Pilkonis, Paul Soloff, Diane Dolata, Harold A. Sackeim, and Roger F. Haskett

Am J Psychiatry 161:2073-2080, November 2004

Age at menarche and depression at the age of 31 years: Findings from the Northern Finland 1966 Birth Cohort Study

Anne Herva, Jari Jokelainen, Anneli Pouta, Juha Veijola, Markku Timonen, Juha T. Karvonen and Matti Joukama

J Psychosomatic Res Vol 57, Issue 4: Pages 359-362 (October 2004)

 

Course of illness in depressive and bipolar disorders. Naturalistic study, 1994–1999

Lars Vedel Kessing, Mette Gerster Hansen, and Per Kragh Andersen

The British Journal of Psychiatry (2004) 185: 372-377

Quality of life and function after electroconvulsive therapy

W. Vaughn McCall, Aaron Dunn, and Peter B. Rosenquist

The British Journal of Psychiatry (2004) 185: 405-409

Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy

Frank J. Vajda, Terence J. O'Brien, Alison Hitchcock, Janet Graham, Mark Cook, Cecilie Lander and Mervyn J. Eadie

Journal of Clinical Neuroscience. Volume 11, Issue 8, November 2004, Pages 854-858

 

Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram
Paul D Carey, James Warwick, Dana JH Niehaus, Geoffrey van der Linden, Barend B van Heerden, Brian H Harvey, Soraya Seedat and Dan J Stein
BMC Psychiatry 2004, 14 October 2004; 4:30

 

Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder
Jeffrey L Berlant
BMC Psychiatry 2004, 14 October 2004;4:24

 

The Burden of Major Depression Avoidable by Longer-term Treatment Strategies

Theo Vos, Michelle M. Haby, Jan J. Barendregt, Michelle Kruijshaar, Justine Corry, Gavin Andrews

Arch Gen Psychiatry. 2004;61:1097-1103

 

Cognitive Enhancers as Adjuncts to Psychotherapy. Use of D-Cycloserine in Phobic Individuals to Facilitate Extinction of Fear

Kerry J. Ressler, Barbara O. Rothbaum, Libby Tannenbaum, Page Anderson, Ken Graap, Elana Zimand, Larry Hodges, Michael Davis

Arch Gen Psychiatry. 2004;61:1136-1144

 

Effects of the Serotonin Transporter Gene Promoter Polymorphism on Mirtazapine and Paroxetine Efficacy and Adverse Events in Geriatric Major Depression

Greer M. Murphy, Jr, Steven B. Hollander, Heidi E. Rodrigues, Charlotte Kremer, Alan F. Schatzberg

Arch Gen Psychiatry. 2004;61:1163-1169

 

Cellular changes in the postmortem hippocampus in major depression

Craig A. Stockmeier, Gouri J. Mahajan, Lisa C. Konick, James C. Overholser, George J. Jurjus, Herbert Y. Meltzer, Harry B.M. Uylings, Lee Friedman and Grazyna Rajkowska

Biological Psychiatry. Volume 56, Issue 9, 1 November 2004, Pages 640-650

 

High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation

Barbara J. Caldarone, Alexia Harrist, Muriel A. Cleary, Robert D. Beech, Sarah L. King and Marina R. Picciotto

Biological Psychiatry. Volume 56, Issue 9 , 1 November 2004, Pages 657-664

 

Psychosocial impairment and recurrence of major depression

David A. Solomon, Andrew C. Leon, Jean Endicott, Timothy I. Mueller, William Coryell, M. Tracie Shea and Martin B. Keller

Comprehensive Psychiatry. Volume 45, Issue 6, November-December 2004, Pages 423-430

 

Longitudinal course of bipolar I disorder

Ivan W. Miller, Lisa A. Uebelacker, Gabor I. Keitner, Christine E. Ryan and David A. Solomon

Comprehensive Psychiatry. Volume 45, Issue 6, November-December 2004, Pages 431-440

 

Factor structure of recalled DSM-IV hypomanic symptoms of bipolar II disorder

Franco Benazzi

Comprehensive Psychiatry. Volume 45, Issue 6, November-December 2004, Pages 441-446

 

Attentional disturbances in patients with unipolar psychotic depression: A selective and sustained attention study

Antonis Politis, Lefteris Lykouras, Polyxeni Mourtzouchou and George N. Christodoulou

Comprehensive Psychiatry. Volume 45, Issue 6, November-December 2004, Pages 452-459

 

Controlled comparison of two different doses of milnacipran in major depressive outpatients.
Kanemoto K, Matsubara M, Yamashita K, Tarao Y, Inada E, Sekine T

Int Clin Psychopharmacol. 2004 Nov;19(6):343-6

 

Treatment-Resistant Posttraumatic Stress Disorder: Strategies for Intervention

Mark B.Hamner, Sophie Robert, and B.Christopher Frueh

CNS Spectr .2004;9(10):740-752

 

Treatment-Resistant Panic Disorder

Borwin Bandelow, and Eckart Rüther

CNS Spectr .2004;9(10):725-730,732-739

 

Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose

Isbister GK, Bowe SJ, Dawson A, Whyte IM.

Journal of Toxicology - Clinical Toxicology 2004;42(3):277-285

 

Bipolar disorders: Special diagnostic and treatment considerations in women.

McElroy SL.

CNS Spectrums 2004;9(8 SUPPL. 7):5-18

Co-morbidity and stability of melancholic features in DSM-IV major depressive disorder

TARJA MELARTIN, ULLA LESKELÄ, HEIKKI RYTSÄLÄ, PETTERI SOKERO, PAULA LESTELÄ-MIELONEN and ERKKI ISOMETSÄ 

Psychological Medicine (2004), 34:8:1443-1452

 

Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders

M. MAJER, M. ISING, H. KÜNZEL, E. B. BINDER, F. HOLSBOER, S. MODELL and J. ZIHL

Psychological Medicine (2004), 34:8:1453-1463

 

Childhood sexual abuse, stressful life events and risk for major depression in women

KENNETH S. KENDLER, JONATHAN W. KUHN and CAROL A. PRESCOTT 

Psychological Medicine (2004), 34:8:1475-1482

 

Juvenile- versus adult-onset depression: multiple differences imply different pathways

JONATHAN HILL, ANDREW PICKLES, LYNN ROLLINSON, RACHEL DAVIES and MARIE BYATT 

Psychological Medicine (2004), 34:8:1483-1493

 

Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse

Charles M. Morin, Lynda Bélanger, Célyne Bastien and Annie Valličres

Behaviour Research and Therapy. Volume 43, Issue 1, January 2005, Pages 1-14

 

Executive Deficits in Elderly Patients With Major Unipolar Depression

Sophie Baudic, Catherine Tzortzis, Gianfranco Dalla Barba, Latchezar Traykov

Journal of Geriatric Psychiatry and Neurology, Vol. 17, No. 4, 195-201 (2004)

Methodology and Preliminary Results From the Neurocognitive Outcomes of Depression in the Elderly Study

David C. Steffens, Kathleen A. Welsh-Bohmer, James R. Burke, Brenda L. Plassman, John L. Beyer, Kenneth R. Gersing, Guy G. Potter

Journal of Geriatric Psychiatry and Neurology, Vol. 17, No. 4, 202-211 (2004)

An Open Treatment Trial of Venlafaxine for Elderly Patients With Dysthymic Disorder

D. P. Devanand, Nicole Juszczak, Mitchell S. Nobler, Nancy Turret, Linda Fitzsimons, Harold A. Sackeim, Steven P. Roose

Journal of Geriatric Psychiatry and Neurology, Vol. 17, No. 4, 219-224 (2004)

 

A prospective randomized single-blind, multicenter trial comparing the efficacy and safety of paroxetine with and without quetiapine therapy in depression associated with anxiety
L. Ilhan Yargic , Aytul Corapcioglu , Nese Kocabasoglu , Ayten Erdogan , Gulsah Koroglu , Dilek Yilmaz

International Journal of Psychiatry in Clinical Practice. Volume 8, Number 4 / December 2004: 205 - 211

 

 

Predicting factors of depression in patients with primary hypertension: a community-based study
Tiemin Wei , Chunlai Zeng , Liping Chen , Suying Wang , Shan Li , Qunying Chen , Lexin Wang

International Journal of Psychiatry in Clinical Practice. Volume 8, Number 4 / December 2004: 213 - 217

 

Quetiapine Versus Placebo in Combination With Lithium or Divalproex for the Treatment of Bipolar Mania
Yatham, Lakshmi N. ; Paulsson, Bjorn ; Mullen, Jamie ; Vagero, Marten

Journal of Clinical Psychopharmacology. 24(6):599-606, December 2004

Predictors of Response to Treatment of Acute Bipolar Manic Episodes With Divalproex Sodium or Placebo in 2 Randomized, Controlled, Parallel-Group Trials
Welge, Jeffrey A. ; Keck, Paul E. Jr ; Meinhold, Jane M

Journal of Clinical Psychopharmacology. 24(6):607-612, December 2004

Association Between SSRI Use and Hip Fractures and the Effect of Residual Confounding Bias in Claims Database Studies
Schneeweiss, Sebastian; Wang, Philip S.

Journal of Clinical Psychopharmacology. 24(6):632-638, December 2004

Impact of the CYP2D6 Ultrarapid Metabolizer Genotype on Mirtazapine Pharmacokinetics and Adverse Events in Healthy Volunteers
Kirchheiner, Julia ; Henckel, Hanns-Benjamin ; Meineke, Ingolf ; Roots, Ivar ; Brockmoller, Jurgen

Journal of Clinical Psychopharmacology. 24(6):647-652, December 2004

S-Adenosyl-L-Methionine (SAMe) as an Adjunct for Resistant Major Depressive Disorder: An Open Trial Following Partial or Nonresponse to Selective Serotonin Reuptake Inhibitors or Venlafaxine
Alpert, Jonathan E. ; Papakostas, George ; Mischoulon, David ; Worthington, John J. III ; Petersen, Timothy ; Mahal, Yasmin ; Burns, Alana ; Bottiglieri, Teodoro ; Nierenberg, Andrew A ; Fava, Maurizio

Journal of Clinical Psychopharmacology. 24(6):661-664, December 2004

Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans

Christoph Schroeder, Jens Tank, David S. Goldstein, Michael Stoeter, Sebastian Haertter, Friedrich C. Luft and Jens Jordan

Clinical Pharmacology & Therapeutics. Volume 76, Issue 5, November 2004, Pages 480-489

 

Is poststroke depression a vascular depression?

Sebastian Dieguez, Fabienne Staub, Laure Bruggimann and Julien Bogousslavsky

Journal of the Neurological Sciences. Volume 226, Issues 1-2, 15 November 2004, Pages 53-58

Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder

Damiaan Denys, Femke de Geus, Harold J. G. M. van Megen and Herman G. M. Westenberg

Psychiatry Research. Volume 128, Issue 3, 30 October 2004, Pages 273-280

 

Heart rate variability in coronary artery disease patients with and without panic disorder

Kim L. Lavoie, Richard P. Fleet, Catherine Laurin, Andre Arsenault, Sydney B. Miller and Simon L. Bacon

Psychiatry Research. Volume 128, Issue 3, 30 October 2004, Pages 289-299

 

 

Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression

Antonia S. New, Monte S. Buchsbaum, Erin A. Hazlett, Marianne Goodman, Harold W

Koenigsberg, Jenni Lo, Lisa Iskander, Randall Newmark, Jesse Brand, Karen O Flynn and Larry J. Siever

Psychopharmacology 2004; Volume 176, Numbers 3-4: 451 - 458

 

 

Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder

Karin Mogg, David S. Baldwin, Paul Brodrick and Brendan P. Bradley

Psychopharmacology 2004; Volume 176, Numbers 3-4: 466 - 470

 

 

Double depression in an Australian population

Robert D. Goldney and Laura J. Fisher

Social Psychiatry and Psychiatric Epidemiology 2004; Volume 39, Number 11: 921 - 926

 

Cycloid psychoses are not part of a bipolar affective spectrum. Results of a controlled family study

B. Pfuhlmann, B. Jabs, G. Althaus, A. Schmidtke, A. Bartsch, G. Stöber, H. Beckmann and E. Franzek

Journal of Affective Disorders. Volume 83, Issue 1, 15 November 2004, Pages 11-19

 

Affective modulation of the startle response in depression: influence of the severity of depression, anhedonia, and anxiety

H. Kaviani, J. A. Gray, S. A. Checkley, P. W. Raven, G. D. Wilson and V. Kumari

Journal of Affective Disorders. Volume 83, Issue 1, 15 November 2004, Pages 21-31

 

Predictors for 2-year outcome of major depressive episode

Erika Szádóczky, Sándor Rózsa, János Zámbori and János Füredi

Journal of Affective Disorders. Volume 83, Issue 1, 15 November 2004, Pages 49-57

 

A meta–analysis of functional neuroimaging in obsessive–compulsive disorder

Stephen P. Whiteside, John D. Port and Jonathan S. Abramowitz

Psychiatry Research: Neuroimaging. Volume 132, Issue 1, 15 November 2004, Pages 69-79

 

Antidepressants and Suicide Risk in the United States, 1985-1999

Michael F. Grunebaum, Steven P. Ellis, Shuhua Li, Maria A. Oquendo, and J. John Mann.

J Clin Psychiatry 2004;65:1456-1462

 

Effect of Lamotrigine on Cognitive Complaints in Patients With Bipolar I Disorder

Arifulla Khan, Lawrence D. Ginsberg, Gregory M. Asnis, Frederick K. Goodwin, Kimberly H. Davis, Anupama A. Krishnan, and Bryan E. Adams

J Clin Psychiatry 2004;65:1483-1490

 

Efficacy and Tolerability of Tranylcypromine Versus Phenelzine: A Double-Blind Study in Antidepressant-Refractory Depressed Inpatients

Tom K. Birkenhäger, Walter W. van den Broek, Paul G. Mulder, Jan A. Bruijn, and Peter Moleman

J Clin Psychiatry 2004;65:1505-1510

 

Combining Stimulants With Monoamine Oxidase Inhibitors: A Review of Uses and One Possible Additional Indication

S. Shalom Feinberg

J Clin Psychiatry 2004;65:1520-1524

 

Impact of Depressive Symptoms Compared With Manic Symptoms in Bipolar Disorder: Results of a U.S. Community-Based Sample

Joseph R. Calabrese, Robert M. A. Hirschfeld, Mark A. Frye, and Michael L. Reed

J Clin Psychiatry 2004;65:1499-1504

 

Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?

L V Kessing and P K Andersen

Journal of Neurology Neurosurgery and Psychiatry 2004;75:1662-1666

Alterations of neuroplasticity in depression: the hippocampus and beyond

Eberhard Fuchs, Boldizsár Czéh, Maarten H.P. Kole, Thomas Michaelis and Paul J. Lucassen

European Neuropsychopharmacology. Volume 14, Issue 1005, December 2004, Pages S481-S490

Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine

Bruce S. McEwen and Sumantra Chattarji

European Neuropsychopharmacology. Volume 14, Issue 1005, December 2004, Pages S497-S502

Neuroplasticity: from MRI to depressive symptoms

Philippe Fossati, Andrei Radtchenko and Patrice Boyer

European Neuropsychopharmacology. Volume 14, Issue 1005, December 2004, Pages S503-S510

From restoration of neuroplasticity to the treatment of depression: clinical experience

Jorge Alberto Costa e Silva

European Neuropsychopharmacology. Volume 14, Issue 1005, December 2004, Pages S511-S521

Electroconvulsive therapy in adolescent and adult psychiatric inpatients—a retrospective chart design

Daniel Stein, Larissa Kurtsman, Shaul Stier, Yulia Remnik, Sorin Meged and Abraham Weizman

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 335-342

 

Functioning after a major depressive episode: complete or incomplete recovery?

Martine A. Buist-Bouwman, Johan Ormel, Ron de Graaf and Wilma A. M. Vollebergh

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 363-371

 

The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program

Lizheng Shi, Patrick Thiebaud and Jeffrey S. McCombs

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 373-383

 

Children of a cohort of depressed patients 25 years later: psychopathology and relationships

C. Peisah, H. Brodaty, G. Luscombe and K. J. Anstey

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 385-394

 

Regional brain responses to serotonin in major depressive disorder

Amy D. Anderson, Maria A. Oquendo, Ramin V. Parsey, Matthew S. Milak, Carl Campbell and J. John Mann

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 411-417

 

Suicide attempts: differences between unipolar and bipolar patients and among groups with different lethality risk

Michele Raja and Antonella Azzoni

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 437-442

 

Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations

Margareta Reis, Anna Ĺberg-Wistedt, Hans Ĺgren, Ann-Charlotte Ĺkerblad and Finn Bengtsson

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 443-446

 

Fish consumption and depression: the Northern Finland 1966 birth cohort study

Markku Timonen, David Horrobin, Jari Jokelainen, Jaana Laitinen, Anne Herva and Pirkko Räsänen

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 447-452

 

Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants

Orli Kampf-Sherf, Zoli Zlotogorski, Asaf Gilboa, Lynn Speedie, Jossef Lereya, Paula Rosca and Yehuda Shavit

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 453-459

 

Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study

Ron de Graaf, Rob V. Bijl, Margreet ten Have, Aartjan T. F. Beekman and Wilma A. M. Vollebergh

Journal of Affective Disorders. Volume 82, Issue 3, 1 November 2004, Pages 461-467

 

The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression

Boghos I. Yerevanian, Jamie D. Feusner, Ralph J. Koek and Jim Mintz

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 103-108

 

Electroconvulsive therapy in depressive illness that has not responded to drug treatment

Syed S. Husain, Ian Mark Kevan, Rebecca Linnell and Allan I.F. Scott

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 121-126

 

Depression in older persons with versus without vascular disease in the open population: similar depressive symptom patterns, more disability

Els Licht-Strunk, Marijke A. Bremmer, Harm W.J. van Marwijk, Dorly J.H. Deeg, Witte J.G. Hoogendijk, Marten de Haan, Willem van Tilburg and Aartjan T.F. Beekman

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 155-160

 

Ethnic differences in first clinical presentation of bipolar disorder: results from an epidemiological study

N. Kennedy, J. Boydell, J. van Os and R.M. Murray

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 161-168

 

Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study

Michael Bauer, Lynn Fairbanks, Anne Berghöfer, Johannes Hierholzer, Tom Bschor, Christopher Baethge, Natalie Rasgon, Johanna Sasse and Peter C. Whybrow

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 183-190

 

Temperament and depressive symptoms: a population-based longitudinal study on Cloninger's psychobiological temperament model

Marko Elovainio, Mika Kivimäki, Sampsa Puttonen, Tarja Heponiemi, Laura Pulkki and Liisa Keltikangas-Järvinen

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 227-232

A comparative study of milnacipran and paroxetine in outpatients with major depression

Daniel Sechter, Pierre Vandel, Emmanuel Weiller, Nicole Pezous, Fabienne Cabanac, Alain Tournoux and the study co-coordinators

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 233-236

 

Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences

Verena Henkel, Roland Mergl, James C. Coyne, Ralf Kohnen, Antje-Kathrin Allgaier, Elke Rühl, Hans-Jürgen Möller and Ulrich Hegerl

Journal of Affective Disorders. Volume 83, Issues 2-3, December 2004, Pages 237-242

 

Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKK and CaMKK mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor

Jonathan Vinet, Serena Carra, Joan M. C. Blom, Nicoletta Brunello, Nicholas Barden and Fabio Tascedda

Neuropharmacology. Volume 47, Issue 7, December 2004, Pages 1062-1069

 

Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by Antidepressants

Welmoed E. E. Meijer, Eibert R. Heerdink, Willem A. Nolen, Ron M. C. Herings, Hubert G. M. Leufkens, Antoine C. G. Egberts

Arch Intern Med. 2004;164:2367-2370

 

 

DRD4 receptor gene exon III polymorphism in inpatient suicidal adolescents

G. Zalsman, A. Frisch, R. Lewis, E. Michaelovsky, H. Hermesh, L. Sher, E. Nahshoni, L. Wolovik, S. Tyano, A. Apter, R. Weizman and A. Weizman

Journal of Neural Transmission 2004; Volume 111, Number 12: 1593 - 1603

 

Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies.
Otto MW, Perlman CA, Wernicke R, Reese HE, Bauer MS, Pollack MH.

Bipolar Disord 2004: 6: 470-479

 

Bipolar depression: phenomenological overview and clinical characteristics.

Mitchell PB, Malhi GS.
Bipolar Disord 2004: 6: 530-539

 

Hippocampal Brain-Derived Neurotrophic Factor Expression Following Treatment with Reboxetine, Citalopram, and Physical Exercise
Amelia A Russo-Neustadt, Hilda Alejandre, Celithelma Garcia, Autumn S Ivy and Michael J Chen

Neuropsychopharmacology (2004) 29, 2189-2199

 

Neuropathologic Correlates of Late-Onset Major Depression
Robert A Sweet, Ronald L Hamilton, Meryl A Butters, Benoit H Mulsant, Bruce G Pollock, David A Lewis, Oscar L Lopez, Steven T DeKosky and Charles F Reynolds III

Neuropsychopharmacology (2004) 29, 2224-2250

 

A Systematic Review of Antidepressant Placebo-Controlled Trials for Geriatric Depression: Limitations of Current Data and Directions for the Future
Warren D Taylor and P Murali Doraiswamy

Neuropsychopharmacology (2004) 29, 2285-2299

 

Use of Selective Serotonin-Reuptake Inhibitors in the Treatment of Depression in Adults with HIV

Joshua Caballero, Milap C Nahata

Annals of Pharmacotherapy. Published online, 23 November 2004, DOI 10.1345/aph.1E248

 

Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
Greist J, McNamara RK, Mallinckrodt CH, Rayamajhi JN, Raskin J

Clin Ther. 2004 Sep;26(9):1446-55

 

Gait unsteadiness and fall risk in two affective disorders: a preliminary study
Jeffrey M Hausdorff, Ck Peng, Ary L Goldberger and Andrew L Stoll
BMC Psychiatry 2004, 24 November; 4:39

 

Hippocampal volume measurement in older adults with bipolar disorder.
Beyer JL, Kuchibhatla M, Payne ME, Moo-Young M, Cassidy F, Macfall J, Krishnan KR

Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):613-20

 

S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS
R. Andrew Shippy, Douglas Mendez, Kristina Jones, Irene Cergnul and Stephen E Karpiak
BMC Psychiatry 2004, 11 November  ; 4:38

.

Regresar a RESÚMENES NOVIEMBRE 2004